Report from the Cortrium3 test University Hospital Zeeland, Oncology Department and palliative Units, Naestved: 2016-2017

The device Cortrium C 3, provided by the company Cortrium, was tested at University Hospital Zeeland, Oncology Department and palliative Units, Naestved. The Department of Clinical Oncology and Palliative Care ensures treatment and care for patients with cancer as well as specialized palliative care for terminal patients. The purpose of the study was to evaluate measurement properties and feasibility of using a Vital sign Monitoring System for cancer patients under treatment. Patients at the oncology ward were asked to participate during their admission to hospital. The test, including patients indicated that: The measurements conducted were constant. The advantages for introducing a vital sign measurement to oncology patients is to reduce the constant disturbance of measuring vital signs day and night ensuring the patients rest to recover as well as easing the workflow for the healthcare professionals conducting measurements. During the test interviews were conducted with healthcare professionals (nurses) as well as patients which could describe their experience of using healthcare devices such as the C 3 during their treatment and care of the patients. Subsequently the interviews with the patients described their experience of using the device.